Product Code: ETC5306083 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
Pneumonia vaccines are vaccines used for immunization against bacterial and viral pathogens such as Streptococcus pneumoniae and Influenza virus, which cause pneumonia and other respiratory infections. This market involves the production, distribution, and administration of pneumonia vaccines for preventive healthcare interventions.
The Israel Pneumonia Vaccine market is experiencing steady growth driven by factors such as increasing awareness about vaccination, rising geriatric population, and the prevalence of respiratory diseases. Pneumonia vaccines play a crucial role in preventing bacterial and viral infections that cause pneumonia, thereby reducing morbidity and mortality rates. Moreover, government initiatives to expand immunization programs and improve healthcare infrastructure contribute to the growth of the pneumonia vaccine market in Israel.
The pneumonia vaccine market in Israel faces challenges related to vaccine availability, accessibility, and public health priorities. Ensuring equitable distribution, vaccination coverage, and affordability while addressing vaccine hesitancy and misinformation poses significant hurdles. Moreover, coordinating vaccination campaigns, monitoring vaccine efficacy, and adapting to evolving epidemiological trends add complexity to the market landscape.
The Israel government implements policies to ensure widespread access to pneumonia vaccines, particularly targeting vulnerable populations such as children, the elderly, and individuals with underlying health conditions. These policies often involve vaccination programs, subsidies for immunization, and public awareness campaigns to promote vaccine uptake. Additionally, the government may collaborate with pharmaceutical companies to secure adequate vaccine supply, regulate vaccine pricing, and monitor vaccine efficacy and safety.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Pneumonia Vaccine Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Pneumonia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Pneumonia Vaccine Market - Industry Life Cycle |
3.4 Israel Pneumonia Vaccine Market - Porter's Five Forces |
3.5 Israel Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Israel Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Israel Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2021 & 2031F |
3.8 Israel Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Pneumonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Israel |
4.2.2 Government initiatives to increase immunization rates |
4.2.3 Growing elderly population in Israel prone to pneumonia |
4.3 Market Restraints |
4.3.1 High cost associated with pneumonia vaccines |
4.3.2 Limited access to healthcare services in certain regions of Israel |
4.3.3 Vaccine hesitancy among some population groups |
5 Israel Pneumonia Vaccine Market Trends |
6 Israel Pneumonia Vaccine Market Segmentations |
6.1 Israel Pneumonia Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021-2031F |
6.1.3 Israel Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021-2031F |
6.2 Israel Pneumonia Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Pneumonia Vaccine Market Revenues & Volume, By Prevnar 13, 2021-2031F |
6.2.3 Israel Pneumonia Vaccine Market Revenues & Volume, By Synflorix, 2021-2031F |
6.2.4 Israel Pneumonia Vaccine Market Revenues & Volume, By Pneumovax 23, 2021-2031F |
6.3 Israel Pneumonia Vaccine Market, By Sector |
6.3.1 Overview and Analysis |
6.3.2 Israel Pneumonia Vaccine Market Revenues & Volume, By Public, 2021-2031F |
6.3.3 Israel Pneumonia Vaccine Market Revenues & Volume, By Private, 2021-2031F |
6.4 Israel Pneumonia Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Israel Pneumonia Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021-2031F |
6.4.3 Israel Pneumonia Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021-2031F |
6.4.4 Israel Pneumonia Vaccine Market Revenues & Volume, By Government Authorities, 2021-2031F |
7 Israel Pneumonia Vaccine Market Import-Export Trade Statistics |
7.1 Israel Pneumonia Vaccine Market Export to Major Countries |
7.2 Israel Pneumonia Vaccine Market Imports from Major Countries |
8 Israel Pneumonia Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates |
8.2 Number of government-funded vaccination campaigns |
8.3 Rate of pneumonia cases among the elderly population |
8.4 Percentage of healthcare facilities offering pneumonia vaccines |
8.5 Number of educational programs on vaccination awareness in Israel |
9 Israel Pneumonia Vaccine Market - Opportunity Assessment |
9.1 Israel Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Israel Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Israel Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2021 & 2031F |
9.4 Israel Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Pneumonia Vaccine Market - Competitive Landscape |
10.1 Israel Pneumonia Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Israel Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |